Agomab Therapeutics
  • Home
  • About Us
    • About Us
    • Executive Committee
    • Board of Directors
    • Investors & Partners
  • Our Science
    • Our Science
    • Publications
  • Our Pipeline
    • Our Pipeline
    • AGMB-129
    • AGMB-447
    • AGMB-101-102
    • Expanded Access
  • News & Events
    • Press Releases
    • Agomab in the news
    • Meet Us
  • Connect with Us
    • Contact us
    • Locations
  • Work with us
Agomab Therapeutics
  • Home
  • About Us
    • About Us
    • Executive Committee
    • Board of Directors
    • Investors & Partners
  • Our Science
    • Our Science
    • Publications
  • Our Pipeline
    • Our Pipeline
    • AGMB-129
    • AGMB-447
    • AGMB-101-102
    • Expanded Access
  • News & Events
    • Press Releases
    • Agomab in the news
    • Meet Us
  • Connect with Us
    • Contact us
    • Locations
  • Work with us

Seasoned Corporate Advisors

September 29th, 2023 Comments Off on Jan van de Winkel

Jan van de Winkel

Read more

September 29th, 2023 Comments Off on Vicky Sato

Vicky Sato

Read more

September 29th, 2023 Comments Off on Brett Saunders

Brett Saunders

Read more

September 29th, 2023 Comments Off on Sheila Gujrathi

Sheila Gujrathi

Read more

September 29th, 2023 Comments Off on John Maraganore

John Maraganore

Read more

September 29th, 2023 Comments Off on Tim van Hauwermeiren

Tim van Hauwermeiren

Read more

Recent Posts

  • Late-Breaking Interim STENOVA Data for AGMB-129 in Fibrostenosing Crohn’s to be Presented at Digestive Disease Week® 2025
  • Agomab Announces Positive Topline Phase 2a Interim Results for AGMB-129 in Fibrostenosing Crohn’s Disease
  • Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors
  • Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis- focused Pipeline
  • Agomab Bolsters Executive Team with Appointment of Pierre Kemula as Chief Financial Officer

Recent Comments

    Archives

    • April 2025
    • March 2025
    • November 2024
    • October 2024
    • July 2024
    • June 2024
    • December 2023
    • November 2023
    • October 2023
    • February 2023
    • September 2022
    • July 2022
    • January 2022
    • December 2021
    • October 2021
    • July 2021
    • June 2021
    • March 2021
    • October 2019
    • April 2019

    Categories

    • –
    • 2019
    • 2021
    • 2022
    • 2023
    • 2024
    • 2025
    • All

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Legal
    Copyright © 2025 Agomab Therapeutics